MannKind Corporation (NASDAQ:MNKD)’s shares gained 5.27% to $7.39. MNKD’s stock was upgraded to Neutral from Underweight at Piper Jaffray citing management’s confidence in Afrezza approval and partnership opportunities. Piper raised price target to $6.50 from $2.0MannKind Corporation (NASDAQ:MKND) weekly performance is 18.88%. On last trading day company shares ended up $9.51. Analysts mean target price for the company is $8.58. Distance from 50-day simple moving average (SMA50) is 44.12%.
Ophthotech Corp (NASDAQ:OPHT) major shareholder Svlsf Iv, Llc unloaded 931,869 shares of the company’s stock in a transaction. The shares were sold at an average price of $40.99, for a total transaction of $38,197,310.31. Following the completion of the transaction, the insider now directly owns 119,593 shares in the company, valued at approximately $4,902,117. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC. Ophthotech Corp (NASDAQ:OPHT) shares advanced 4.58% in last trading session and ended the day on $41.75. Its return on assets is -45.70 %. Quarterly performance is 10.86%.
A number of other firms have also recently commented on ALDR. Analysts at Wells Fargo & Co. initiated coverage on shares of Alder Biopharmaceuticals in a research note on Monday. They set an “outperform” rating on the stock. Analysts at Leerink Swann initiated coverage on shares of Alder Biopharmaceuticals in a research note. Alder Biopharmaceuticals Inc (NASDAQ:ALDR) shares moved up 6.44 % in last trading session and was closed at $13.05, while trading in range of $12.34-$13.50. Year to date (YTD) performance is 30.11%.
Investment analysts at Bank of America assumed coverage on shares of Vital Therapies Inc (NYSE:VTL) in a note issued to investors. The firm set a “buy” rating on the stock. Vital Therapies Inc (NASDAQ:VTL) rose 5.83 percent to $12.70 volume of 51.11K shares. Vital Therapies Inc (NASDAQ:VTL) has a market capitalization of $268.22million.Vital Therapies Inc (NASDAQ:VTL) ended the last trading day at $13.97. Company weekly volatility is calculated as 8.48% and showed a positive weekly performance of 16.03%.